As the use for medical cannabis continues to increase combined with the recent FDA approval of cannabidiol for two rare forms of epilepsy, many pharmacists are considering what role they may play in caring for patients who use medical cannabis.
In this archived webinar, an expert in the field will discuss the potential mechanisms of action of cannabis, various formulations and uses for medical cannabis, patient safety issues including potential drug interactions, and communication strategies for discussing cannabis use with patients. There are many implications medical cannabis could have for the profession of pharmacy, and pharmacists should be equipped to respond to patients considering the use of cannabis.
At the completion of this knowledge-based activity, participants will be able to:
- Describe the clinical pharmacology of cannabis and its active components.
- Evaluate clinical studies that have been performed in patients with various conditions using cannabis. Identify potential drug interactions and other patient safety issues that may occur with the use of cannabis.
- Identify potential drug interactions and other patient safety issues that may occur with the use of cannabis.
- Discuss communication strategies for talking with patients who are using medical cannabis.
Activity type: Knowledge-based
Target Audience: Pharmacists & Pharmacy Technicians
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. The following activity is approved for 1.0 contact hour of CPE credit (0.1 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-18-257-H04-P/T.
To obtain credit for completing Medical Cannabis: Implications for the Practice of Pharmacy (Home Study), watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: October 17, 2018
Expiration date: October 17, 2021
Medical Cannabis: Implications for the Practice of Pharmacy (Home Study) is an archived, online educational activity for pharmacists and pharmacy technicians developed by the American Pharmacists Association.
Laura M. Borgelt, PharmD, FCCP, BCPS, declares receiving honoraria as a speaker for PharmCon Inc. and the Marijuana for Medical Professionals conference.
APhA’s editorial staff declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association.
There is no fee for current APhA Members. This online educational activity is available exclusively to APhA members for the first 30 days of release, as a free member benefit. Thereafter, non-members can purchase this activity at a cost of $129.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.